Enrolling Clinical Studies
Flu and Covid-19 Vaccines in One.
Healthy 65 Years of Age and Older
This study will evaluate the safety, tolerability, and immunogenicity of combined vaccine against Covid-19 and Influenza in healthy individuals.
Requirements:
• Male or female 65+
• Healthy individuals or individuals with preexisting stable disease.
• Participants with a BMI between 18 to 35 kg/m2
• No individuals who tested positive for Influenza by a local health authority within 180 days.
• No individual who received treatment with antiviral therapy (Tamiflu) for Influenza
• No history of myocarditis, pericarditis, cardiomyopathy, coronary artery disease.
• No history of adverse reaction to egg protein or any vaccine.
• No individuals with known immunodeficiency, dementia or suicidal ideation/behavior.
• No individuals who has received any Influenza or COVID-19 vaccine within 150 days before Day1
Study Duration:
This study consist of 4 office visits and 1 telephone contact in the term of 6 month.
Compensation:
$180/Visit up to $720 in total